LINC00324 is aberrantly expressed in 11 cancers, and dysregulated LINC00324 is also associated with poor prognosis and clinical characteristics, including tumor size, lymph node metastasis, tumor TNM stage, and clinical stage in cancer patients. The gene discussed is LINC00324; the disease is neoplasm.